2021
DOI: 10.1002/psp4.12689
|View full text |Cite
|
Sign up to set email alerts
|

Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr

Abstract: Pharmacokinetic (PK) parameter estimation is a critical and complex step in the model‐informed precision dosing (MIPD) approach. The mapbayr package was developed to perform maximum a posteriori Bayesian estimation (MAP‐BE) in R from any population PK model coded in mrgsolve. The performances of mapbayr were assessed using two approaches. First, “test” models with different features were coded, for example, first‐order and zero‐order absorption, lag time, time‐varying covariates, Michaelis–Menten elimination, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 39 publications
0
9
0
Order By: Relevance
“…Therefore, nine sets of PK parameters were obtained for each PK model for each patient. The R package mapbayr was used for PK parameter estimation [ 38 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, nine sets of PK parameters were obtained for each PK model for each patient. The R package mapbayr was used for PK parameter estimation [ 38 ].…”
Section: Methodsmentioning
confidence: 99%
“…In this method, the objective function values (OFVs) for estimating the PK parameters for each model were processed and used as weights. The OFVs were then calculated using the R package mapbayr for PK parameter estimation [ 38 ]. The OFV was processed to a weight using the following equation: where is the number of the th PK model out of the nine models used for parameter estimation.…”
Section: Methodsmentioning
confidence: 99%
“…For example, for posologyr::poso_dose_auc with p = 0.5, posologyr will determine the optimal dose so that 50% of the probable profiles reach or exceed the target AUC. [17]. The 35 population pharmacokinetic models (Table 1) were transcribed for posologyr (an example is given in Appendix A): default monocompartmental with linear elimination, bicompartmental, with various absorption models (lag-time, zero order, first order, combination of zero and first order kinetics, bioavailability), with nonlinear Michaelis-Menten elimination associated or not with linear elimination, with time-varying covariates, different residual error models (additive, proportional, mixed, log-additive), with two types of observations (parent-metabolite model), and finally with increasing levels of inter-individual variability (with variances ranging from 0.2 to 2).…”
Section: Dosing Adjustmentmentioning
confidence: 99%
“…To allow comparability of the results of the performance evaluation of the MAP algorithm of posologyr, the primary endpoints were identical to those proposed by Le Louedec et al [17]. The maximum absolute difference was obtained between posologyr (η ik, PGYR ) and NONMEM (η ik,N M ) for each individual according to the following expressions:…”
Section: Performance Analysis 261 Point Estimate: Mapmentioning
confidence: 99%
“…In addition, P mean k is the mean of population PK parameter, P EST k is the estimated individual PK parameter, and ω is the interindividual variability of the PK parameters for the k-th parameter of a total of L parameters. The MAP estimation was conducted using the R package mapbayr [36].…”
Section: Map Estimationmentioning
confidence: 99%